Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.

Anja Lorch; Antje Kleinhans; Andrew Kramar; Christian K Kollmannsberger; Jörg T Hartmann; Carsten Bokemeyer; Oliver Rick; Jörg Beyer

doi:10.1200/JCO.2011.38.6391

Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.

Anja Lorch
Antje Kleinhans
Andrew Kramar
Christian K Kollmannsberger
Jörg T Hartmann
Carsten Bokemeyer
Oliver Rick
Jörg Beyer

Related Research units

II. Department of Medicine

Abstract

To evaluate the long-term survival rates in patients with relapsed or refractory germ cell tumors (GCTs) after single or sequential high-dose chemotherapy (HDCT).

Bibliographical data

Original language	English
Article number	8
ISSN	0732-183X
DOIs	https://doi.org/10.1200/JCO.2011.38.6391
Publication status	Published - 10.03.2012